The Economic Burden of Cancers Attributable to Metabolic Syndrome in Korea
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
Abstract
Objectives: Metabolic syndrome is an important etiologic factor in the development of certain types of cancers. The economic cost of the treatment of cancer has been steadily increasing. We therefore estimated the economic burden of cancers attributable to metabolic syndrome in Korea. Methods: We reviewed metabolic syndrome-related cancers and relative risk and then calculated population attributable fractions. We analyzed insurance claims data for metabolic syndrome-related cancers in 2012 in order to estimate the direct costs associated with these cancers, including hospitalization, outpatient visits, transportation costs, and caregivers’ costs as well as indirect costs such as loss of productivity due to cancer treatment and premature death. Results: In 2012, 18 070 patients in Korea had cancers attributable to metabolic syndrome. The economic burden was USD 199.8 million and the direct and indirect costs were USD 124.5 million and USD 75.3 million, respectively. Conclusions: We estimated the economic burden of cancers attributable to metabolic syndrome in Korea and the efforts are necessary to reduce this burden.
참고문헌 (26)
- Lim S, "Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007", Diabetes Care, 34(6), pp.1323~1328 (2011)
- 오상우, "Obesity and Metabolic Syndrome in Korea", Diabetes and Metabolism Journal, 35(6), pp.561~566 (2011), 대한당뇨병학회
- Braun S, "The link between the metabolic syndrome and cancer", Int J Biol Sci, 7(7), pp.1003~1015 (2011)
- Bjørge T, "Metabolic syndrome and endometrial carcinoma", Am J Epidemiol, 171(8), pp.892~902 (2010)
- Esposito K, "Metabolic syndrome and risk of cancer: a systematic review and metaanalysis", Diabetes Care, 35(11), pp.2402~2411 (2012)
- Esposito K, "Colorectal cancer association with metabolic syndrome and its components: a systematic review with metaanalysis", Endocrine, 44(3), pp.634~647 (2013)
- National Health Insurance Service, "National health insurance statistical yearbook 2012", pp.84~ (2014), National Health Insurance Service
- "Death and death rates by cause"[URL]
- Park S, "Populationattributable causes of cancer in Korea: obesity and physical inactivity", PLoS One, 9(4), pp.e90871~ (2014)
- 김진희, "2005년 암의 경제적 비용부담 추계", 예방의학회지, 42(3), pp.190~198 (2009), 대한예방의학회
- 변주영, "Economic Burden of Colorectal Cancer in Korea", 예방의학회지, 47(2), pp.84~93 (2014), 대한예방의학회
- Häggström C, "Metabolic factors associated with risk of renal cell carcinoma", PLoS One, 8(2), pp.e57475~ (2013)
- Ulmer H, "Metabolic risk factors and cervical cancer in the metabolic syndrome and cancer project (Me-Can)", Gynecol Oncol, 125(2), pp.330~335 (2012)
- Nagel G, "Metabolic risk factors and skin cancer in the Metabolic Syndrome and Cancer Project (Me-Can)", Br J Dermatol, 167(1), pp.59~67 (2012)
- Levin ML, "The occurrence of lung cancer in man", ActaUnioInt Contra Cancrum, 9(3), pp.531~541 (1953)
- Shin A, "Population attributable fraction of infection-related cancers in Korea", Ann Oncol, 22(6), pp.1435~1442 (2011)
- Gold MR, "Cost-effectiveness in health and medicine", pp.20~ (1996), Oxford University Press
- "The average exchange rate of 2012"[URL]
- Health insurance patients payments survey, 2010, "Park M", National Health Insurance Corporation, 15~ (2011)
- The subjects for advancement in private employment service, "Jang SC", Korea Labor Institute, 57~ (2013)
- Kim Y, "Costing methods in healthcare", National Evidence-based Healthcare Collaborating Agency, 120~ (2013)
- "Statistics of employment and labor"[URL]
- Luengo-Fernandez R, "Economic burden of cancer across the European Union: a population-based cost analysis", Lancet Oncol, 14(12), pp.1165~1174 (2013)
- 강재헌, "Socioeconomic Costs of Overweight and Obesity in Korean Adults", Journal of Korean Medical Science, 26(12), pp.1533~1540 (2011), 대한의학회
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011", Cancer Research and Treatment, 46(2), pp.109~123 (2014), 대한암학회
- Yabroff KR, "Economic burden of cancer in the United States: estimates, projections, and future research", Cancer Epidemiol Biomarkers Prev, 20(10), pp.2006~2014 (2011)